Please login to the form below

Not currently logged in

Publicis adds Heartbeat to portfolio

Digital agency will merge with Saatchi Health agencies in the US
Publicis Groupe logo

Publicis Groupe has acquired the digital agency Heartbeat Ideas, merging it with its Saatchi Health agencies in the US.

Founded in 1998, Heartbeat has a staff of 90, divided between offices in New York and California. Clients included Galderma, Janssen Pharmaceuticals, Novartis, Pfizer, Sanofi, Teva and XenoPort. 

Publicis Groupe's New York-based Saatchi & Saatchi Health Communications and Saatchi & Saatchi Wellness will now operate as one entity under the latter name. 

Heartbeat Ideas and its sister agency, Heartbeat West, will operate as 'Heartbeat Ideas, a member of Saatchi & Saatchi Wellness' and 'Heartbeat West, a member of Saatchi & Saatchi Wellness'. Both are full-service agencies within the healthcare space.

Founder and chief executive officer Bill Drummy will remain at the helm of Heartbeat, joining the leadership team at Saatchi & Saatchi Wellness alongside co-managing directors Kathy Delaney and JD Cassidy.

The newly combined agency and leadership team will report to Sam Welch, Publicis Healthcare Communications Group (PHCG) global group president. Kathy Delaney will also retain her role as a global chief creative officer at PHCG.

Heartbeat's existing management team will also remain in place, as will its independent locations in New York's TriBeCa neighbourhood and in Santa Monica, California.

“By becoming a member of Publicis Groupe and Saatchi & Saatchi Wellness, we have the opportunity to be a critical ingredient in an entirely new agency formulation for healthcare clients,” said Drummy.

PHCG president and chief executive officer Nick Colucci added: “This demonstrates our deep understanding of our clients' need to have a communications partner that can look at their brands holistically and provide interconnected solutions.”

The acquisition – announced less than a month after Publicis acquired Indian agency Beehive – is a reflection of the group's 'continued investment in digital', according to chief operating officer Jean-Yves Naouri. 

Article by
Tara Craig

5th November 2013

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...